250 studies found for:    Open Studies | UCSD OR UC San Diego OR VA San Diego
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | UCSD OR UC San Diego OR VA San Diego
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia
Interventions: Drug: PF-04449913;   Drug: Low dose ARA-C (LDAC);   Drug: Decitabine;   Drug: Daunorubicin;   Drug: Cytarabine
2 Recruiting Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: palbociclib;   Drug: Cetuximab;   Drug: Placebo
3 Recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
4 Recruiting A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In 1st Line MDS, AML and CMML Patients
Condition: Myelodysplastic Syndrome
Interventions: Drug: PF-04449913 (Glasdegib);   Drug: Azacitidine;   Drug: PF-04449913 (Glasdegib) Placebo
5 Recruiting A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, Follicular;   Lymphoma, Large B-Cell, Diffuse;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Renal Cell;   Carcinoma, Squamous Cell of Head and Neck
Interventions: Drug: PF-05082566;   Drug: rituximab
6 Recruiting Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib
Condition: Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Glasdegib (PF-04449913);   Drug: Placebo
7 Recruiting Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: PF-06747775
8 Recruiting A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Interventions: Drug: PF-05082566;   Drug: KW-0761
9 Recruiting Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients
Condition: ALK-positive Advanced NSCLC
Interventions: Drug: Crizotinib;   Drug: Pembrolizumab
10 Unknown  24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
Condition: Glaucoma
Intervention: Device: SLT (selective laser trabeculoplasty ) SENSIMED Triggerfish
11 Recruiting Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Condition: Acute HIV Infection
Intervention: Other: Nucleic Acid Amplification Testing
12 Recruiting A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Placebo;   Drug: CP690,550;   Drug: CP-690,550
13 Recruiting Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Condition: Abdominal Aortic Aneurysm (AAA)
Intervention: Device: Nellix System
14 Recruiting A Prospective, Single Arm, Multi-Center Clinical Study in Collaboration With the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS®) to Evaluate the Thoracotomy Implant Technique of the HeartWare HVAD® System in Patients With Advanced Heart Failure
Condition: Left Sided Heart Failure
Intervention: Device: HeartWare HVAD
15 Recruiting Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Condition: Advanced Cancer
Intervention: Drug: MGCD265
16 Recruiting Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
Condition: Breast Cancer
Interventions: Radiation: Photon;   Radiation: Proton
17 Recruiting Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
18 Unknown  The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
19 Not yet recruiting Trauma Informed Guilt Reduction Therapy
Conditions: Guilt;   Shame;   Post-traumatic Stress Disorders
Interventions: Behavioral: Trauma Informed Guilt Reduction Therapy;   Behavioral: Supportive Care Therapy
20 Recruiting CER-001 Atherosclerosis Regression ACS Trial
Condition: Acute Coronary Syndromes
Interventions: Drug: CER-001;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years